Liquidia (LQDA) Change in Account Payables (2020 - 2026)

Liquidia's (LQDA) quarterly Change in Account Payables came in at $562000.0 in Q1 2026, down 83.56% year-on-year from $3.4 million in Q1 2025, and up 128.62% quarter-over-quarter from -$2.0 million in Q4 2025.

Liquidia (LQDA) Change in Account Payables (2020 - 2026) Analysis & Trends

Liquidia's Change in Account Payables history runs 7 years deep, the most recent figure standing at $562000.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 83.56% year-over-year to $562000.0 in Q1 2026; TTM through Mar 2026 was -$5.4 million, a 200.07% decrease from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 211.29% from the prior year.
  • Change in Account Payables grew to $562000.0 in Q1 2026 per LQDA's latest filing, from -$2.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.4 million in Q1 2025 and bottomed at -$6.0 million in Q3 2025.
  • The 5-year median for Change in Account Payables is $303000.0 (2024), against an average of -$2294.1.
  • Across the five-year window, Change in Account Payables slumped 1857.95% in 2024 and soared 1028.05% in 2025, its largest moves.
  • Year by year, Change in Account Payables stood at $1.0 million in 2022, then tumbled by 158.6% to -$596000.0 in 2023, then surged by 528.19% to $2.6 million in 2024, then tumbled by 176.96% to -$2.0 million in 2025, then jumped by 128.62% to $562000.0 in 2026.
  • Per Business Quant, the three latest LQDA Change in Account Payables figures stand at $562000.0 (Q1 2026), -$2.0 million (Q4 2025), and -$6.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 562,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 562,000.00
Mar 31, 2026 562,000.00
Dec 31, 2025 -1.96 Mn
Dec 31, 2025 -1.96 Mn
Sep 30, 2025 -5.99 Mn
Sep 30, 2025 -5.99 Mn
Jun 30, 2025 1.95 Mn
Jun 30, 2025 1.95 Mn
Mar 31, 2025 3.42 Mn
Mar 31, 2025 3.42 Mn
Dec 31, 2024 2.55 Mn
Dec 31, 2024 2.55 Mn
Sep 30, 2024 -3.45 Mn
Sep 30, 2024 -3.45 Mn
Jun 30, 2024 2.92 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2024 303,000.00
Mar 31, 2024 303,000.00
Dec 31, 2023 -596,000.00
Dec 31, 2023 -596,000.00